Cohen Robert 4
4 · Zomedica Corp. · Filed Jun 1, 2021
Insider Transaction Report
Form 4
Cohen Robert
Director
Transactions
- Exercise/Conversion
Common Stock, without par value
2021-06-01$0.19/sh+2,000,000$380,000→ 2,000,000 total - Sale
Common Stock, without par value
2021-06-01$0.81/sh−3,193,750$2,595,880→ 0 total - Exercise/Conversion
Stock option (right to buy)
2021-06-01−1,193,750→ 10,806,250 totalExercise: $0.23Exp: 2030-12-30→ Common Stock, without par value (1,193,750 underlying) - Exercise/Conversion
Common Stock, without par value
2021-06-01$0.23/sh+1,193,750$274,563→ 3,193,750 total - Exercise/Conversion
Stock option (right to buy)
2021-06-01−2,000,000→ 0 totalExercise: $0.19Exp: 2025-06-16→ Common Stock, without par value (2,000,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.8499 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]Options fully vested.
- [F4]The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021.